Overview
Description
Olympus Corp. engages in the manufacture and sale of precision machineries and instruments. It operates through the following segments: Medical, Scientific Solutions, Imaging, and Others. The Medical segment covers digestive, surgical, and ultrasonic endoscopy as well as endoscopic treatment tools. The Scientific Solutions segment manufactures and sells biological and industrial microscopes, industrial endoscopes, and non-destructive testing equipment. The Imaging segment deals with digital cameras and recording devices. The Others segment includes biomaterial manufacturing and sales business. The company was founded by Takeshi Yamashita on October 12, 1919 and is headquartered in Tokyo, Japan.
Healthcare Healthcare Equipment General Medical Devices Japan
Financials
Key metrics
Market capitalisation, EUR | 13,444.38 m |
EPS, EUR | 0.63 |
P/B ratio | 2.91 |
P/E ratio | 18.80 |
Dividend yield | 1.03% |
Income statement (2024)
Revenue, EUR | 6,101.44 m |
Net income, EUR | 720.67 m |
Profit margin | 11.81% |
What ETF is Olympus Corp. in?
There are 214 ETFs which contain Olympus Corp.. All of these ETFs are listed in the table below. The ETF with the largest weighting of Olympus Corp. is the Ossiam Bloomberg Japan PAB NR UCITS ETF H1C (EUR Hedged).
— Data provided by Trackinsight, etfinfo, Xignite Inc., gettex, FactSet and justETF GmbH.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.
Quotes are either real-time (gettex) or 15 minutes delayed stock exchange quotes or NAVs (daily published by the fund provider). By default, ETF returns include dividend payments (if applicable). There is no warranty for completeness, accuracy and correctness for the displayed information.